CliffBio
small molecule

QVAR 40

BECLOMETHASONE DIPROPIONATE

Loss of exclusivityMay 2031latest FDA-listed patent expiry
CompanyTEVA BRANDED PHARMACEUTICAL PRODUCTS R AND D LLC

Drug detail

Brand nameQVAR 40
Active ingredientBECLOMETHASONE DIPROPIONATE
Strength0.04MG/INH **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Dosage formAEROSOL, METERED
RouteINHALATION
ModalitySmall molecule
FDA approvalSeptember 2000
Marketing statusDISCN

Listed patents

PatentExpiresType
10022510May 2031product
10086156May 2031product
9808587May 2031product
9463289May 2031product
10022509May 2031product

More from TEVA BRANDED PHARMACEUTICAL PRODUCTS R AND D LLC

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.

QVAR 40 patent cliff — loss of exclusivity May 2031 | CliffBio